Ras and Pik3ca mutations are mutually exclusive in endometrial and breast cancers, but co-exist in colorectal and lung tumors [31,157,158,159], suggesting that the acquisition of both mutations may confer additional characteristics that are beneficial for the tumor. This evidence concerns the gene PIK3CA and breast cancer.